Development and Validation of a Stability-Indicating RP-HPLC Method for Edaravone Quantification

Development and Validation of a Stability-Indicating RP-HPLC Method for Edaravone Quantification

Edaravone is used to treat motor neurone disease (MND) by slowing disease progression and prolonging survival time. Currently, it is available as an IV infusion (Radicava<sup>®</sup>, Jersey City, NJ, USA) and an oral liquid suspension (Radicava ORS<sup>®</sup>, Jersey City,...

Full description

Saved in:

Bibliographic Details
Main Authors:	Riuna O’Neill, Okhee Yoo, Philip Burcham, Minh Nguyen, Lee Yong Lim
Format:	Article
Language:	English
Published:	MDPI AG 2025-07-01
Series:	Molecules
Subjects:	edaravone HPLC motor neurone disease assay stability
Online Access:	https://www.mdpi.com/1420-3049/30/13/2866
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Antioxidant and Apoptotic Effect of Edaravone on Cisplatin-Induced Brain Injury in Rats
by: Ozlem Kara, et al.
Published: (2024-01-01)

Edaravone Dexborneol Treatment Attenuates Neuronal Apoptosis and Improves Neurological Function by Suppressing 4-HNE-Associated Oxidative Stress After Subarachnoid Hemorrhage
by: Qian Chen, et al.
Published: (2022-04-01)

Edaravone's Safety Profile in Acute Ischemic Stroke
by: Laurence K. J. Batino, et al.
Published: (2024-12-01)

Corrigendum: Edaravone dexborneol treatment attenuates neuronal apoptosis and improves neurological function by suppressing 4-HNE-associated oxidative stress after subarachnoid hemorrhage
by: Qian Chen, et al.
Published: (2024-12-01)

Edaravone dexborneol compared to edaravone in the treatment of acute cerebral infarction: A meta-analysis
by: Yanshuo Shi, et al.
Published: (2025-06-01)

The protective effect of Edaravone against acute renocardiac syndrome in a kidney ischemia-reperfusion model
by: Yasin Bagheri, et al.
Published: (2024-12-01)

Development of Green RP-HPLC method for determination of sorafenib in film-coated tablets
by: Sanija Zulfikjari, et al.
Published: (2024-12-01)

The effect of Edaravone on clinical symptoms and oxidative stress factors in patients with acute ischemic stroke: A clinical trial
by: Mojtaba Khazaei, et al.
Published: (2024-04-01)

Edaravone dexborneol provides neuroprotective benefits by suppressing ferroptosis in experimental intracerebral hemorrhage
by: Han Li, et al.
Published: (2025-05-01)

Edaravone Attenuates Sleep Deprivation-Induced Memory Deficits by Inhibiting Oxidative Stress and Neuroinflammation in Murine Models
by: Shiliang Ji, et al.
Published: (2025-04-01)

Cost-utility analysis for sublingual versus intravenous edaravone in the treatment of amyotrophic lateral sclerosis
by: Chang Liu, et al.
Published: (2024-10-01)

Adverse events reporting of edaravone: a real-world analysis from FAERS database
by: Qi Shang, et al.
Published: (2025-03-01)

Simultaneous stability-indicating analysis of nateglinide and pioglitazone using RP-HPLC
by: Sriparni Das, et al.
Published: (2025-12-01)

DEVELOPMENT AND VALIDATION OF A NEW RP-HPLC METHOD FOR SIMULTANEOUS DETERMINATION AND QUANTIFICATION OF SOFOSBUVIR AND DACLATASVIR
by: Syed Hassan Murtaza, et al.
Published: (2024-03-01)

Association between edaravone use and activities of daily living in older patients with atherothrombotic stroke: an observational study using Japanese real-world data
by: Yukari Ogawa, et al.
Published: (2025-01-01)

Amyotrophic lateral sclerosis: pathogenetic mechanisms and new approaches to pharmacotherapy (literature review)
by: T. M. Alekseeva, et al.
Published: (2019-01-01)

Edaravone dexborneol alleviates pericyte-mediated fibrosis depositing extracellular matrix through TGF-β1/IL-11 in cerebral small vessel disease
by: Qingrui Duan, et al.
Published: (2025-02-01)

Edaravone Dexborneol provides neuroprotective effect by inhibiting neurotoxic activation of astrocytes through inhibiting NF-κB signaling in cortical ischemia
by: Zhe Chen, et al.
Published: (2024-11-01)

Development and Validation of RP-HPLC Method for the Determination of Dexrabeprazole Sodium
by: Semra Yılmazer Keskin, et al.
Published: (2021-12-01)

Edaravone reduces the markers of oxidative stress and neuroinflammation in neocortex of rats with acute intracerebral hemorrhage and type 2 diabetes mellitus
by: V. L. Holubiev, et al.
Published: (2024-12-01)

Neuroprotective effect and possible mechanism of edaravone in rat models of spinal cord injury: a systematic review and network meta-analysis
by: Long-yun Zhou, et al.
Published: (2025-04-01)

Green and white analytical approach for parallel quantification of gabapentin and methylcobalamin in medicinal products using inventive RP-HPLC technique
by: Samar M. Mahgoub, et al.
Published: (2025-06-01)

Stability indicating RP-HPLC method development and validation for the determination of pyrimethamine in an oral paediatric suspension
by: Sahra Muhammad, et al.
Published: (2024-12-01)

Edaravone-Dexborneol slows down pathological progression and cognitive decline via inhibiting S100A9 in APPswe/PS1dE9 mice
by: Rui Mao, et al.
Published: (2025-06-01)

Impressive stability-indicating RP-HPLC method for concurrent quantification of salbutamol, guaifenesin, and sodium benzoate in cough syrup: Application of six sigma and green metrics
by: Alanazi Tahani Y. A., et al.
Published: (2025-01-01)

Development and validation of stability indicating RP-HPLC method for nebivolol by using the DOE approach
by: Anant Ghongade, et al.
Published: (2025-06-01)

Evaluation of possible approaches to the determination by the method rp hplc natural oils in repellent compositions
by: L. A. Nosikova, et al.
Published: (2015-10-01)

Analytical HPLC-separation of retinoid derivatives of natural and 3,4-didehydro series
by: N. E. Belikov, et al.
Published: (2014-02-01)

Peculiarities of neuroprotective therapy in women with acute ischemic stroke
by: O. A. Halushko, et al.
Published: (2020-08-01)

Development and Validation of Analytical HPLC Method for Identification and Assay of Enoxaparin Sodium in Injectable Preparations
by: E. A. Pshenichnov, et al.
Published: (2023-02-01)

ANALYSIS OF INSECTICIDE GELS CONTAINING FIPRONIL BY RP HPLC
by: L. A. Nosikova, et al.
Published: (2018-04-01)

Edaravone dexborneol protected neurological function by targeting NRF2/ARE and NF-κB/AIM2 pathways in cerebral ischemia/reperfusion injury
by: Hui Zhang, et al.
Published: (2025-04-01)

Stability indicating RP-HPLC method for estimation of finerenone and its related substances in new dosage form
by: Aya A. Marie, et al.
Published: (2025-06-01)

Development and validation of a stability-indicating RP-HPLC method for tizanidine hydrochloride using DOE
by: Prasad Gunjal, et al.
Published: (2025-06-01)

Identification and assessment of novel degradants in pazopanib hydrochloride using stability-indicating RP-HPLC method
by: Rohit Prajapati, et al.
Published: (2025-12-01)

A novel RP-HPLC stability-indicating method for simultaneous estimation of Niraparib and Abiraterone in synthetic mixtures and combined tablet formulations
by: Krishnaphanisri Ponnekanti, et al.
Published: (2025-05-01)

Stability indicating RP-HPLC technique for simultaneous estimation of nirmatrelvir and ritonavir in their new copackaged dosage form for COVID-19 treatment
by: Mohamed G. Yassin, et al.
Published: (2025-01-01)

Novel RP-HPLC method for quantification of peramivir and its impurity (1H-1,2,4-triazole-1-carboximidamide) in bulk and injectable preparations
by: Anitha Nandagopal, et al.
Published: (2025-05-01)

Development and validation of a RP-HPLC method for the quantisation studies of metronidazole and furazolidone from product Enteroguard M
by: Elena Gabriela Oltean,, et al.
Published: (2010-12-01)

Simultaneous Quantification of Main Saponins in <i>Panax vietnamensis</i> by HPLC-PDA/ELSD Using the Quantitative Analysis of Multi-Components by Single-Marker Method
by: Thi-My-Duyen Ngo, et al.
Published: (2025-06-01)